2016
DOI: 10.4103/2303-9027.193594
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound contrast agents

Abstract: Endoscopic ultrasound (EUS) plays an important role in imaging of the mediastinum and abdominal organs. Since the introduction of US contrast agents (UCA) for transabdominal US, attempts have been made to apply contrast-enhanced US techniques also to EUS. Since 2003, specific contrast-enhanced imaging was possible using EUS. Important studies have been published regarding contrast-enhanced EUS and the characterization of focal pancreatic lesions, lymph nodes, and subepithelial tumors. In this manuscript, we de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
72
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 100 publications
(74 citation statements)
references
References 97 publications
0
72
0
2
Order By: Relevance
“…In addition, 91 of 102 PNETs (89%) were hyperenhancing or isoenhancing, resulting in a correct differential diagnosis of PDAC and non-PDAC in 189 of 219 patients (86%) [32]. The results using CEUS were better compared to CT; CT did not delineate a focal pancreatic lesion in 14 of the 38 patients with complete reports of CE-EUS and CT (37%; PDAC, n=6 and PNET, n=8; median diameter 8 mm [range, 4 to 12 mm]) [32] and the ultrasound contrast agent SonoVue was highly sensitive due to being strictly intravascular [65]. These results are in concordance with the findings published for more than 1,000 histologically proven focal pancreatic lesions and in earlier studies using CEUS techniques [29,49].…”
Section: Contrast-enhanced Ultrasonography And/or Contrast-enhanced Ementioning
confidence: 99%
“…In addition, 91 of 102 PNETs (89%) were hyperenhancing or isoenhancing, resulting in a correct differential diagnosis of PDAC and non-PDAC in 189 of 219 patients (86%) [32]. The results using CEUS were better compared to CT; CT did not delineate a focal pancreatic lesion in 14 of the 38 patients with complete reports of CE-EUS and CT (37%; PDAC, n=6 and PNET, n=8; median diameter 8 mm [range, 4 to 12 mm]) [32] and the ultrasound contrast agent SonoVue was highly sensitive due to being strictly intravascular [65]. These results are in concordance with the findings published for more than 1,000 histologically proven focal pancreatic lesions and in earlier studies using CEUS techniques [29,49].…”
Section: Contrast-enhanced Ultrasonography And/or Contrast-enhanced Ementioning
confidence: 99%
“…This prevents quick dissolution of the microbubble and allows these microbubbles to persist in the circulation for several minutes. Overviews of the composition of the different ultrasound contrast agents used in imaging research have been provided previously . In short, the first generation contrast agents consisted of air‐filled microbubbles with a lipid shell while the second generation microbubbles contain gases with a low solubility in water.…”
Section: Contrast Agents; Composition Generations and Brandsmentioning
confidence: 99%
“…Although offering a useful adjunct, transabdominal ultrasound examinations with high frequency transducers cannot substitute scanning with a low frequency transducers. We also refer to the use of contrast enhanced endoscopic ultrasound in the detection of superficially located liver tumours [38,[41][42][43].…”
Section: Discussionmentioning
confidence: 99%